Management Team:

Thomas Tillett - President & CEO

Lorraine H. Keller, Ph.D. - CSO

Carl Johnson, DVM - CMO

Board of Directors:

Christopher Cashman, Chairman - Former CEO Marinus Pharmaceuticals

Thomas Tillett, President & CEO - MBF Therapeutics

Chris Bunge - Watermill Asset Management

Board Observer - Dr. Anthony Green - Director of Investments, Ben Franklin Technology Partners Southeastern PA

Corporate Counsel:

Kathleen Shay, Partner - Duane Morris LLP

  • LinkedIn Classic
  • Facebook Classic
  • Twitter Social Icon

​Follow us at @mbftherapeutics

© 2013 MBF Therapeutics